The independently run business will be renamed Bovis, its original identity going back 140 years, and will be led by chief executive David Cadiot.

Mycobacterium abscessus is a fast-growing, pathogenic mycobacteria that can cause lung infections, and people who have respiratory conditions or are immunocompromised face a higher risk.